Gufic Biosciences Ltd.
Snapshot View

View in App

Prices View details >>

197.55 +2.10 ▲1.1%

22 March 2023, 02:57:22 PM
Volume: 46,672

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gufic.com
Market Cap 1,933.56 Cr.
Enterprise Value(EV) 2,031.87 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.44 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 23.62 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 34.01 Trailing Twelve Months Ending 2022-12
Price to Book Value 5.86 Calculated using Price: 199.45
Dividend Yield 0.05 Period Ending 2022-03
No. of Shares Subscribed 9.69 Cr. 96,944,506 Shares
FaceValue 1
Company Profile
Gufic Biosciences Ltd. is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.07%
1 Week
-0.68%
1 Month
-7.84%
3 Month
-9.13%
6 Month
-12.28%
1 Year
-18.28%
2 Year
+84.28%
5 Year
+80.74%
10 Year
+3112.20%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.55 15.60 23.99 25.31 36.03 33.89 22.17 29.22 43.31
Return on Capital Employed (%) 17.45 18.38 24.24 24.26 34.10 29.65 21.01 30.05 47.10
Return on Assets (%) 4.25 3.49 5.24 5.52 8.04 8.04 5.65 10.00 20.98

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 26 27 34 37 54 75 129 173 269 309
Non Curr. Liab. 25 17 15 9 13 17 38 55 65 130
Curr. Liab. 60 84 104 128 169 218 326 164 187 255
Minority Int.
Equity & Liab. 111 127 152 175 235 310 493 392 521 694
Non Curr. Assets 42 36 33 31 37 46 134 131 201 260
Curr. Assets 69 91 120 143 198 264 359 261 321 435
Misc. Exp. not W/O
Total Assets 111 127 152 175 235 310 493 392 521 694

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 123 152 202 246 306 351 379 488 779 680
Other Income 1 1 1 1 3 4 6 4 3 2
Total Income 124 152 203 247 308 355 385 491 782 682
Total Expenditure -111 -137 -183 -223 -267 -305 -327 -404 -633 -549
PBIDT 13 15 20 24 42 50 58 88 149 133
Interest -4 -4 -6 -6 -9 -10 -14 -14 -5 -6
Depreciation -2 -4 -4 -4 -4 -5 -14 -16 -17 -18
Taxation -2 -2 -3 -5 -13 -13 -7 -13 -31 -27
Exceptional Items 2
PAT 4 4 7 9 16 22 23 44 96 82
Adjusted EPS 1 1 1 1 2 3 2 5 10 8

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 11 11 -4 -4 -5 5 47 87 104
Cash Fr. Inv. -13 -3 -2 -1 -5 -9 -13 -43 -7 -96
Cash Fr. Finan. 8 -7 -5 5 7 14 8 -4 -79 -3
Net Change 0 1 4 0 -1 1 0 0 2 5
Cash & Cash Eqvt 1 3 6 6 3 4 4 4 6 12

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 65.75 65.75 65.13 75.48 75.48 75.48 75.00 75.00 75.00
Public 34.25 34.25 34.87 24.52 24.52 24.52 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 24 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Gufic Biosciences Limited has informed the Exchange about Transcript
Tue, 21 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Gufic Biosciences Limited has informed the Exchange about
Thu, 16 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Gufic Biosciences Limited has informed the Exchange about Schedule of meet

Technical Scans View Details >>

Tue, 21 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,471.25 +1.2%
Divi's Laboratories Ltd. 73,553.38 2,789.85 +0.8%
Cipla Ltd. 69,632.88 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. 51,277.87 1,516.95 +0.1%
Zydus Lifesciences Ltd. 48,378.30 479.20 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-12 26.39 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 479.20 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-12 3.07 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 479.20 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.20 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.20 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.20 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.20 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 971.85 +1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,471.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,789.85 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 861.65 -0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,279.90 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,516.95 +0.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.20 +0.2%

FAQ's On Gufic Biosciences Ltd.

What is Gufic Biosciences share price?
Can I buy Gufic Biosciences shares now?
What is the Dividend Yield of Gufic Biosciences?
What is the Market Cap of Gufic Biosciences?
What are the key metrics to analyse Gufic Biosciences?
What is the 52 Week High and Low of Gufic Biosciences?
What is the trend of Gufic Biosciences share price?